Skip to search formSkip to main contentSkip to account menu

Non-Commercial Sources

A category used for classifying sources of research reagents obtained through academic institutions.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
A REVIEW OF NON CONVENTIONAL ENERGY SOURCES
Energy is the key input to drive an improve the life cycle. Primarily, it is the gift of the nature to the mankind in various… 
2013
2013
Gene Patents in Australia: A Game Theory Approach
I. INTRODUCTIONGene patents represent one of the most controversial issues in modern patent law. The controversy concerns whether… 
Review
2011
Review
2011
Healthcare Technology Co-Operatives: Filling a Niche in the English R&D Landscape.
The Department of Health (England) commissioned this evaluation of the pilot Health Technology Cooperatives (HTCs), which are… 
2010
2010
Microsatellite and phenological descriptors identify eastern black walnut cultivars in Missouri, USA.
An applied breeding program focused on the improvement of eastern black walnut (Juglans nigra) for edible nut production was… 
Review
2009
Review
2009
Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory Group
n Australia, provision of specialised product information and promotion by the pharmaceutical industry of drugs approved by the… 
2006
2006
More money for medical research
Returns from increased funding need to be evaluated 
2006
2006
Evaluating films for high transmission attenuated phase shift masks
Three types of high transmission attenuated phase shift masks were evaluated. The attenuating materials were obtained from… 
1998
1998
The Bristol shipping industry in the sixteenth century
As the title of this thesis indicates, it is concerned with Bristol’s sixteenth century shipping industry. The bulk of the study… 
1987
1987
Introducing a new drug into your practice.
Many consultations in family practice end with a prescription for medication. The average market life of a new drug is only five… 
1976
1976
Contaminating antibodies in anti-IgE antisera.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)